Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Estradiol synthesis is a biochemical process in which the steroid hormone estradiol is produced from cholesterol, through several enzyme-catalyzed steps. The main enzymes involved are aromatase (CYP19A1), which converts androgens to estrogens, and 17β-hydroxysteroid dehydrogenase, which converts estrone to estradiol. This process occurs primarily in the ovaries (granulosa cells), testes, adrenal cortex, adipose tissue, and other peripheral sites. Dysregulation of estradiol synthesis is implicated in various diseases, including cancers (such as breast and endometrial cancer), endocrine disorders, and conditions like endometriosis. Therapeutically, the pathway is targeted indirectly by drugs that inhibit or modulate the activity of key enzymes, such as aromatase inhibitors used in hormone-dependent breast cancer.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Estradiol synthesis.